Originally Posted by
Lux Flyer
....
Because DL and AA aren't as bullish as UA is, which AA/DL's decisions are also reflected in their financials. And as much as people want to say UA's success is due to death of the product by a thousand "Kirby Kuts", TRASM doesn't grow by 26% because of cutting the product. I don't think many people are interested in following AA's example right now when it comes to pricing decisions.
Q4 operating income:
UA $1.39B
DL $1.43B
DL was slightly ahead in Q3, too